Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Galleon Pharmaceuticals
company
About
Galleon Pharmaceuticals is engaged in the discovery and development of medicines for breathing-control conditions in the United States.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $10M
- Industries
- Biotechnology,Life Science,Pharmaceutical
- Founded date
- Jan 1, 2003
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Galleon Pharmaceuticals engages in the discovery and development of medicines for breathing-control conditions in the United States. It focuses on developing a portfolio of therapeutics for the treatment of sleep apnea, ventilator weaning, anesthetic/analgesic-induced respiratory depression, COPD, obesity-hypoventilation syndrome, and other common diseases. The company was incorporated in 2003 and is based in Horsham, Pennsylvania.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$10M
Galleon Pharmaceuticals has raised a total of
$10M
in funding over 2 rounds. Their latest funding was raised on
Jun 11, 2015 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 11, 2015 | Series B | $10M | 1 | — | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
